Nxera Pharma Co., Ltd.
4565.T·Tokyo
1,314.00+118.00 (+9.87%)today
As of Oct 21, 3:13 PM JST · May be delayed up to 20 min · JPY
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close1,196.00
Open1,224.00
Day range1,219.001,349.00
52-week range723.001,349.00
Off day high−2.59%
Off 52-week high−2.59%
Volume2.40M
Avg. volume (3M)997.54K
Market cap120.53B
EPS (TTM)-88.12
Forward P/E29.31
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding91.73M
Short interest—
Earnings dateOct 30, 2026
Analyst target—
Profit margin—
Against its peers
Compare in full ›| 4565.T | JAZZ | AXSM | NMRA | ACAD | XENE | |
|---|---|---|---|---|---|---|
| Market cap | 120.53B | 13.76B | 8.21B | 78.16M | 3.47B | 3.48B |
| P/E (TTM) | — | 14.5 | — | — | 9.0 | — |
| Forward P/E | 29.3 | 8.2 | 42.4 | -0.6 | 21.9 | -7.6 |
| Price/book | 1.9 | 2.9 | 98.4 | 1.7 | 2.7 | 2.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +23.81% | +54.32% | +23.02% | −72.81% | −4.44% | −14.01% |
| Today | +9.87% | −0.84% | −1.76% | −10.54% | −1.52% | −0.88% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All 4565.T news ›Nxera Pharma Enters into Exclusive License, Supply and Commercialization Agreement with Synmosa for QUVIVIQ® (daridorexant) Across Eight Asia-Pacific Markets
Insomnia disorder is defined as difficulty initiating or maintaining sleep, causing clinically significant distress or impairment in important areas of daytime functioning. As defined this impact on sleep quantity or quality should be…
From articles in the 4Search news index.
In the news
1mentions in 30 days
1with it in the headline
Mixedsentiment
Mentioned with
Most coverage from
-
daily-tribune.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.